Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
US12296002B2 · kind B2 · utility
0Cited by
5References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 18, 2021 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Sep 29, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/10071
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially to an immunogenic composition having a recombinant SARS-CoV-2 S protein and adjuvant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.